Colorectal cancer - Driven by inflammation and gut bacteria?

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 10, 2012, Pages 558-

  Ray, Katrina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BIOLOGICAL MARKER; COLIBACTIN; DNA; INTERLEUKIN 10; TOXIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; COLITIS; COLORECTAL CANCER; COMMENSAL ESCHERICHIA COLI; DISEASE ASSOCIATION; DISEASE MODEL; DNA DAMAGE; ENTEROCOCCUS FAECALIS; GENE DELETION; GENOTOXICITY; HUMAN; INTESTINE FLORA; NONHUMAN; NOTE; PATHOGENICITY ISLAND; PRIORITY JOURNAL; WILD TYPE;

EID: 84867199359     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.172     Document Type: Note

References (1)

1. Desreumaux, P. et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology doi:10.1053/j.gastro.2012.07.116